to remove filtersEC to ease prescription drug ad rules
19 Jul 2001 | by MATTHEW ARNOLD
drugs such as Novartis' Starlyx, asthma brands such as Astra Zeneca's Oxix, and anti-AIDS drugs such ...
Search results for "Asthma"
Add Search Filters:
By Date
- 19-Jul-2001 (4)
By Publication
- Marketing (4)
By News Type
- News (4)
By Discipline
- Marketing (4)
- Public Relations (2)
EC to ease prescription drug ad rules
19 Jul 2001 | by MATTHEW ARNOLD
drugs such as Novartis' Starlyx, asthma brands such as Astra Zeneca's Oxix, and anti-AIDS drugs such ...
PUBLIC RELATIONS: How to target the informed patient - An EC move could allow drugs firms to market direct to consumers, writes Mary Cowlett
19 Jul 2001 | by MARY COWLETT
- asthma, diabetes and HIV/AIDS. This means that pharma companies may soon be allowed to enter ...
PUBLIC RELATIONS: How to target the informed patient - An EC move could allow drugs firms to market direct to consumers, writes Mary Cowlett
19 Jul 2001 | by MARY COWLETT
- asthma, diabetes and HIV/AIDS. This means that pharma companies may soon be allowed to enter ...
Additional Information
Latest jobs Jobs web feed
-
PR Manager
BOC Group
Competitive salary and benefits , Guildford Surrey -
Associate Director - Consumer Health and Fitness
Reuben Sinclair
up to £70k, pus benefits - personalised training programme, healthcare, early finish fridays..., Central London -
Business Development Manager - Public Relations
PR Futures
£30-£40k+package, London -
Head of campaigns - PR
Samsung
Competitive Salary + Bonus + Benefits, South East region -
Head of B2B PR
Samsung
Competitive Salary + Bonus + Benefits, South East region
Most read
- George Pitcher sets out plans for Jericho Chambers to overcome 'redundant' PR model
- Sony to split consumer electronics PR brief in two putting Cake on alert
- The real influencers in Westminster outnumber lobbyists
- Frank to handle launch of mobile gaming system Moga
- NHS ratchets up role of PR to refocus on service's reputation
- Albion Drive picks up six-figure brief for Nominet Trust
